No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with Familial Hypercholesterolemia compared to usual care: results of a randomised controlled trial
Open Access
- 10 April 2012
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 5 (1) , 181
- https://doi.org/10.1186/1756-0500-5-181
Abstract
People with Familial Hypercholesterolemia (FH) may benefit from lifestyle changes supporting their primary treatment of dyslipidaemia. This project evaluated the efficacy of an individualised tailored lifestyle intervention on lipids (low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), total cholesterol (TC) and triglycerides), systolic blood pressure, glucose, body mass index (BMI) and waist circumference in people with FH.Keywords
This publication has 44 references indexed in Scilit:
- Can Multiple Lifestyle Behaviours Be Improved in People with Familial Hypercholesterolemia? Results of a Parallel Randomised Controlled TrialPLOS ONE, 2012
- Physical activity and dietary behavior change in Internet-based weight loss interventions: Comparing two multiple-behavior change indicesPreventive Medicine, 2011
- Short and long term effects of a lifestyle intervention for construction workers at risk for cardiovascular disease: a randomized controlled trialBMC Public Health, 2011
- Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment GoalPLOS ONE, 2010
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEuropean Journal of Preventive Cardiology, 2009
- Title pageThe American Journal of Cardiology, 2008
- The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with DyslipidemiaThe American Journal of Cardiology, 2008
- Multiple health behavior change research: An introduction and overviewPreventive Medicine, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisPublished by Elsevier ,2008
- Familial hypercholesterolemia—Improving treatment and meeting guidelinesInternational Journal of Cardiology, 2003